Prenatal stress and developmental programming of human health and disease risk: Concepts and integration of empirical findings

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 17, Issue 6, 2010, Pages 507-516

  Entringer, Sonja ^a   Buss, Claudia ^a   Wadhwa, Pathik D ^a,b  

^a Department of Psychiatry and Human Behavior ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

childhood obesity; developmental programming; maternal placental fetal endocrine and immune processes; metabolic function; prenatal stress

Indexed keywords

C REACTIVE PROTEIN; CORTICOTROPIN; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PEPTIDE YY; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; BODY COMPOSITION; CHILD DEVELOPMENT; CLINICAL PRACTICE; CORTICOTROPIN BLOOD LEVEL; DISEASE ASSOCIATION; EMPIRICISM; EPIGENETICS; FEEDBACK SYSTEM; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IMMUNE FUNCTION TEST; LIVER; MATERNAL STRESS; MENTAL STRESS; METABOLISM; NERVE CELL MEMBRANE POTENTIAL; OBESITY; PANCREAS; PHENOTYPE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; PRENATAL STRESS; REVIEW; SIGNAL TRANSDUCTION; SMALL FOR DATE INFANT; STRESS;

ANIMALS; DISEASE SUSCEPTIBILITY; FEMALE; FETAL DEVELOPMENT; HEALTH STATUS; HUMANS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 78649327876     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283405921     Document Type: Review

References (124)

1. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science 2004; 305:1733-1736.
2. Glynn LM, Wadhwa PD, Dunkel-Schetter C, et al. When stress happens matters: effects of earthquake timing on stress responsivity in pregnancy. Am J Obstet Gynecol 2001; 184:637-642.
3. Feldman PJ, Dunkel-Schetter C, Sandman CA, Wadhwa PD. Maternal social support predicts birth weight and fet al growth in human pregnancy. Psy-chosom Med 2000; 62:715-725.
4. Rini CK, Dunkel-Schetter C, Wadhwa PD, Sandman CA. Psychological adaptation and birth outcomes: the role of personal resources, stress, and sociocultural context in pregnancy. Health Psychol 1999; 18:333-345.
5. Wadhwa PD, Sandman CA, Porto M, et al. The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation. Am J Obstet Gynecol 1993; 169:858-865.
6. Wadhwa PD, Dunkel-Schetter C, Chicz-DeMet A, et al. Prenatal psychoso-cial factors and the neuroendocrine axis in human pregnancy. Psychosom Med 1996; 58:432-446.
7. Wadhwa PD, Sandman CA, Chicz-DeMet A, Porto M. Placental CRH modulates maternal pituitary adrenal function in human pregnancy. Ann N Y Acad Sci 1997; 814:276-281.
8. Wadhwa PD, Garite TJ, Porto M, et al. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fet al growth restriction: a prospective investigation. Am J Obstet Gynecol 2004; 191:1063-1069.
9. Wadhwa PD, Porto M, Garite TJ, et al. Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy. Am J Obstet Gynecol 1998; 179:1079-1085.
10. Behrman RE, Stith Butler A, editors. Committeeon understanding premature birth and assuring healthy outcomes. Washington, DC: National Academies Press; 2007.
11. Langley-Evans SC, McMullen S. Development alorigins of adult disease. Med Princ Pract 2010; 19:87-98.
12. Wadhwa PD. Psychoneuroendocrine processes in human pregnancy influ-ence fet al development and health. Psychoneuroendocrinology 2005; 30:724-743.
13. Tataranni PA, Larson DE, Snitker S, et al. Effects of glucocorticoidsonenergy metabolism and food intake in humans. Am J Physiol 1996; 271 (2 Pt 1): E317-E325.
14. George SA, Khan S, Briggs H, Abelson JL. CRH-stimulated cortisol release and food intake in healthy, nonobese adults. Psychoneuroendocrinology 2010; 35:607-612.
15. Gonzalez-Bono E, Rohleder N, Hellhammer DH, et al. Glucose but not protein or fat load amplifies the cortisol response to psychosocial stress. Horm Behav 2002; 41:328-333.
16. Hitze B, Hubold C, van Dyken R, et al. How the selfish brain organizes its supply and demand. Front Neuroenergetics 2010; 2:7.
17. Epel E, Lapidus R, McEwen B, Brownell K. Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology 2001; 26:37-49.
18. Coe CL, Lubach GR, Shirtcliff EA. Maternal stress during pregnancy pre-disposes for iron deficiency in infant monkeys impacting innate immunity. Pediatr Res 2007; 61 (5 Pt 1):520-524.
19. Bailey MT, Lubach GR, Coe CL. Prenatal stress alters bacterial colonization of the gut in infant monkeys. J Pediatr Gastroenterol Nutr 2004; 38:414-421.
20. Coe CL, Lulbach GR, Schneider ML. Prenatal disturbance alters the size of the corpus callosum in young monkeys. Dev Psychobiol 2002; 41: 178-185.
21. Coe CL, Lubach GR, Karaszewski JW. Prenatal stress and immune recogni-tion ofselfand nonself in the primate neonate. Biol Neonate 1999; 76:301-310.
22. Bowman RE, MacLusky NJ, Sarmiento Y, et al. Sexually dimorphic effects of prenatal stress on cognition, hormonal responses, and central neurotrans-mitters. Endocrinology 2004; 145:3778-3787.
23. Entringer S, Wust S, Kumsta R, et al. Prenatal psychosocial stress exposure is associated with insulin resistance in young adults. Am J Obstet Gynecol 2008; 199:498.e1-498.e7.
24. Entringer S, Kumsta R, Nelson EL, et al. Influence of prenatal psychosocial stress on cytokine production in adult women. Dev Psychobiol 2008; 50:579-587.
25. Heim C, Newport DJ, Heit S, et al. Pituitary-adrenaland autonomic responses tostressin women aftersexual and physical abuse in childhood. JAMA 2000; 284:592-597.
26. Entringer S, Buss C, Kumsta R, et al. Prenatal psychosocial stress exposure is associated with subsequent working memory performance in young women. Behav Neurosci 2009; 123:886-893.
27. Buss C, Davis EP, Muftuler LT, et al. High pregnancy anxiety during mid-gestation is associated with decreased gray matter density in 6-9-year-old children. Psychoneuroendocrinology 2010; 35:141-153.
28. Li J, Olsen J, Vestergaard M, et al. Prenatal stress exposure related to maternal bereavement and risk of childhood overweight. PLoS One 2010; 5:e11896.
29. Beijers R, Jansen J, Riksen-Walraven M, de Weerth C. Maternal prenatal anxiety and stress predict infant illnesses and health complaints. Pediatrics 2010; 126:e401-e409.
30. Merrill JE. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 1992; 14:1-10.
31. Matthews SG. Antenatal glucocorticoidsand programming ofthedeveloping CNS. Pediatr Res 2000; 47:291-300.
32. Zhao B, Schwartz JP. Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives. J Neurosci Res 1998; 52:7-16.
33. Trejo JL, Cuchillo I, Machin C, Rua C. Maternal adrenalectomy at the early onset of gestation impairs the postnatal development of the rat hippocampal formation: effects on cell numbers and differentiation, connectivity and calbindin-D28k immunoreactivity. J Neurosci Res 2000; 62:644-667.
34. Garbrecht MR, Klein JM, Schmidt TJ, Snyder JM. Glucocorticoid metabolism in the human fet al lung: implicationsforlung developmentand the pulmonary surfactant system. Biol Neonate 2006; 89:109-119.
35. Cole TJ, Blendy JA, Monaghan AP, et al. Targeted disruption of the gluco-corticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995; 9:1608-1621.
36. Yen SC. Endocrinology of pregnancy. In: Creasy, RK, Resnick R, editors. Maternal-fet al medicine: principles and practice. Philadelphia, PA: WB Saunders; 1994.
37. Mastorakos G, Ilias I. Maternal and fet al hypothalamic-pituitary-adrenal axes during pregnancyand postpartum. Ann N YAcad Sci 2003; 997:136-149.
38. Harris A, Seckl J. Glucocorticoids, prenatal stress and the programming of disease. Horm Behav 2010. [Epub ahead of print]
39. Cheng YH, Nicholson RC, King B, et al. Corticotropin-releasing hormone gene expression in primary placental cells is modulated by cyclic adenosine 3',5'-monophosphate. J Clin Endocrinol Metab 2000; 85:1239-1244.
40. Lowry PJ. Corticotropin-releasing factor and its binding protein in human plasma. Ciba Found Symp 1993; 172:108-115; discussion 15-28.
41. Weetman AP. Immunity, thyroid function and pregnancy: molecular mechanisms. Nat Rev Endocrinol 2010; 6:311-318.
42. Chrousos GP, Gold PW. The concepts of stress and stress system dis-orders. Overview of physical and behavioral homeostasis. JAMA 1992; 267:1244-1252.
43. Elenkov IJ, Chrousos GP. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 1999; 10:359-368.
44. Entringer S, Buss C, Shirtcliff EA, et al. Attenuation of maternal psychophy-siological stress responses and the maternal cortisol awakening response overthe course of human pregnancy. Stress 2010; 13:258-268.
45. Buss C, Entringer S, Reyes JF, et al. The maternal cortisol awakening response in human pregnancy is associated with the length of gestation. Am J Obstet Gynecol 2009; 201:398.e1-398.e8.
46. Coussons-Read ME, Okun ML, Schmitt MP, Giese S. Prenatal stress alters cytokinelevels in amannerthat mayendangerhuman pregnancy. Psychosom Med 2005; 67:625-631.
47. Christian LM, Franco A, Glaser R, Iams JD. Depressive symptoms are associated with elevated serum proinflammatory cytokines among pregnant women. Brain Behav Immun 2009; 23:750-754.
48. Christian LM, Franco A, Iams J, et al. Depressive symptoms predict exag-gerated inflammatory responses to an in vivo immune challenge among pregnantwomen. Brain Behav Immun 2010; 24:49-53.
49. Petraglia F, Calza L, Garuti GC, et al. New aspects of placental endocrinol-ogy. J Endocrinol Invest 1990; 13:353-371.
50. Petraglia F, Sawchenko PE, Rivier J, Vale W. Evidencefor local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987; 328:717-719.
51. Petraglia F, Sutton S, Vale W. Neurotransmitters and peptides modulate the release of immunoreactive corticotropin-releasing factor from cultured human placental cells. Am J Obstet Gynecol 1989; 160:247-251. (Pubitemid 19055300)
52. Goland RS, Conwell IM, Warren WB, Wardlaw SL. Placental corticotropin-releasing hormone and pituitary-adrenal function during pregnancy. Neuro-endocrinology 1992; 56:742-749.
53. Chan EC, Smith R, Lewin T, et al. Plasma corticotropin-releasing hormone, beta-endorphin and cortisol inter-relationships during human pregnancy. Acta Endocrinol (Copenhagen) 1993; 128:339-344.
54. Florio P, Zatelli MC, Reis FM, et al. Corticotropin releasing hormone: a diagnostic marker for behavioral and reproductive disorders? Front Biosci 2007; 12:551-560.
55. Petraglia F, Aguzzoli L, Florio P, et al. Maternal plasma and placental immunoreactive corticotrophin-releasing factor concentrations in infection-associated term and preterm delivery. Placenta 1995; 16:157-164.
56. Stallmach T, Hebisch G, Joller H, et al. Expression pattern of cytokines in the different compartments of the feto-maternal unit under various conditions. Reprod Fertil Dev 1995; 7:1573-1580.
57. Harville EW, Savitz DA, Dole N, et al. Stress and placental resistance measured by Doppler ultrasound in early and mid-pregnancy. Ultrasound Obstet Gynecol 2008; 32:23-30.
58. LaMarca BD, Ryan MJ, Gilbert JS, et al. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep 2007; 9:480-485.
59. Varvarigou AA, Petsali M, Vassilakos P, Beratis NG. Increased cortisol concentrations in the cord blood of newborns whose mothers smoked during pregnancy. J Perinat Med 2006; 34:466-470.
60. Shen Q, Li ZQ, Sun Y, et al.The role ofpro-inflammatoryfactors in mediating the effects on the fetus of prenatal undernutrition: implications for schizo-phrenia. Schizophr Res 2008; 99:48-55.
61. Paul K, Boutain D, Agnew K, et al. The relationship between racial identity, income, stressand C-reactive protein among parouswomen: implicationsfor preterm birth disparity research. J Natl Med Assoc 2008; 100:540-546.
62. Ford SP, Zhang L, Zhu M, et al. Maternal obesityaccelerates fet al pancreatic beta-cell but not alpha-cell development in sheep: prenatal consequences. Am J Physiol Regul Integr Comp Physiol 2009; 297:R835-R843.
63. Bloomfield FH, Oliver MH, Hawkins P, et al. Periconceptional undernutrition in sheep accelerates maturation of the fet al hypothalamic-pituitary-adrenal axis in late gestation. Endocrinology 2004; 145:4278-4285.
64. Chadio SE, Kotsampasi B, Papadomichelakis G, et al. Impact of maternal undernutrition on the hypothalamic-pituitary-adrenal axis responsiveness in sheep at different ages postnatal. J Endocrinol 2007; 192:495-503.
65. Dwyer CM, Stickland NC. The effects of maternal undernutrition on maternal and fet al serum insulin-like growth factors, thyroid hormones and cortisol in the guinea pig. J Dev Physiol 1992; 18:303-313.
66. Lingas R, Dean F, Matthews SG. Maternal nutrient restriction (48 h) modifies brain corticosteroid receptor expression and endocrine function in the fet al guinea pig. Brain Res 1999; 846:236-242.
67. Bispham J, Gopalakrishnan GS, Dandrea J, et al. Maternal endocrine adaptation throughout pregnancy to nutritional manipulation: consequences for maternal plasma leptin and cortisol and the programming of fet al adipose tissue development. Endocrinology 2003; 144:3575-3585.
68. Florio P, Imperatore A, Sanseverino F, et al. The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein im-proves the early prediction of preeclampsia. J Clin Endocrinol Metab 2004; 89:4673-4677.
69. Ng EK, Leung TN, Tsui NB, et al. The concentration of circulating cortico-tropin-releasing hormone mRNA in maternal plasma is increased in pre-eclampsia. Clin Chem 2003; 49:727-731.
70. Florio P, Romero R, Chaiworapongsa T, et al. Amniotic fluid and umbilical cord plasma corticotropin-releasing factor (CRF), CRF-binding protein, adrenocorticotropin, and cortisol concentrations in intraamniotic infection and inflammation at term. J Clin Endocrinol Metab 2008; 93:3604-3609.
71. Halfon N, Newacheck PW. Evolving notions of childhood chronic illness. JAMA 2010; 303:665-666.
72. Van Cleave J, Gortmaker SL, Perrin JM. Dynamics of obesity and chronic health conditions among children and youth. JAMA 2010; 303:623-630.
73. Butte NF, Christiansen E, Sorensen TIA. Energy imbalance underlying the development of childhood obesity. Obesity 2007; 15:3056-3066.
74. Muhlhausler B, Smith SR. Early-life origins of metabolic dysfunction: role of the adipocyte. Trends Endocrinol Metab 2009; 20:51-57.
75. Kensara OA, Wootton SA, Phillips DI, et al. Fet al programming of body composition: relation between birth weight and body composition measured with dual-energy X-ray absorptiometry and anthropometric methods in older Englishmen. Am J Clin Nutr 2005; 82:980-987.
76. Ibanez L, Suarez L, Lopez-Bermejo A, et al. Early development of visceral fat excess after spontaneous catch-up growth in children with low birth weight. J Clin Endocrinol Metab 2008; 93:925-928.
77. Ibanez L, Ong K, Dunger DB, de Zegher F. Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children.J Clin Endocrinol Metab 2006; 91:2153-2158.
78. Gillman MW, Rich-Edwards JW, Huh S, et al. Maternal corticotropin-releas- ing hormone levels during pregnancy and offspring adiposity. Obesity (Silver Spring) 2006; 14:1647-1653.
79. Fasting MH, Oken E, Mantzoros CS, et al. Maternal levels of corticotropin-releasing hormone during pregnancy in relation to adiponectin and leptin in early childhood. J Clin Endocrinol Metab 2009; 94:1409-1415.
80. Radaelli T, Uvena-Celebrezze J, Minium J, et al. Maternal interleukin-6: marker of fet al growth and adiposity. J Soc Gynecol Investig 2006; 13:53-57.
81. Devaskar SU. Neurohumoral regulation of body weight gain. Pediatr Diabetes 2001; 2:131-144.
82. Mietus-Snyder ML, Lustig RH. Childhood obesity: adrift in the 'limbic triangle'. Annu Rev Med 2008; 59:147-162.
83. Bouret SG. Early life origins of obesity: role of hypothalamic programming. J Pediatr Gastroenterol Nutr 2009; 48 (Suppl 1):S31-S38.
84. Richard D, Huang Q, Timofeeva E. The corticotropin-releasing hormone system in the regulation of energy balance in obesity. Int J Obes Relat Metab Disord 2000; 24 (Suppl 2):S36-S39.
85. Leal-Cerro A, Soto A, Martinez MA, et al. Influence of cortisol status on leptin secretion. Pituitary 2001;4:111-116.
86. Martin RJ, Hausman GJ, Hausman DB. Regulation of adipose cell develop-ment in utero. Proc Soc Exp Biol Med 1998; 219:200-210.
87. Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr 1992; 12:207-233.
88. Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature 2008; 453:783-787.
89. Grammatopoulos D. The family of corticotropin-releasing hormone (CRH) peptides: important regulators of adipocyte function. Endocr Abstracts 2008; 16:S19.1.
90. Coppack SW. Proinflammatory cytokinesand adiposetissue. Proc Nutr Soc 2001; 60:349-356.
91. Muhlhausler BS, Adam CL, Findlay PA, et al. Increased maternal nutrition alters development of the appetite-regulating network in the brain. FASEB J 2006; 20:1257-1259.
92. Muhlhausler BS, Duffield JA, McMillen IC. Increased maternal nutrition stimulates peroxisome proliferator activated receptor-gamma, adiponectin, and leptin messenger ribonucleic acid expression in adipose tissue before birth. Endocrinology 2007; 148:878-885.
93. McMillen IC, Robinson JS. Developmental origins of the metabolic syn-drome: prediction, plasticity, and programming. Physiol Rev 2005; 85:571-633.
94. Padoan A, Rigano S, Ferrazzi E, et al. Differences in fat and lean mass proportions in normal and growth-restricted fetuses. Am J Obstet Gynecol 2004; 191:1459-1464.
95. Crescenzo R, Samec S, Antic V, et al. A role for suppressed thermogenesis favoring catch-up fat in the pathophysiology of catch-up growth. Diabetes 2003; 52:1090-1097.
96. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab 2000; 85:1401-1406.
97. Nyirenda MJ, Lindsay RS, Kenyon CJ, et al. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxy-kinase and glucocorticoid receptor expression and causes glucose intoler-ance in adult offspring. J Clin Invest 1998; 101:2174-2181.
98. Lillycrop KA, Phillips ES, Torrens C, et al. Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPAR alpha promoter of the offspring. Br J Nutr 2008; 100:278-282.
99. Lillycrop KA, Slater-Jefferies JL, Hanson MA, et al. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br J Nutr 2007; 97:1064-1073.
100. Schwitzgebel VM, Somm E, Klee P. Modeling intrauterinegrowth retardation in rodents: impact on pancreas development and glucose homeostasis. Mol Cell Endocrinol 2009; 304:78-83.
101. Speiser PW, Rudolf MC, Anhalt H, et al.Childhood obesity.J Clin Endocrinol Metab 2005; 90:1871-1887.
102. O'Rahilly S, Farooqi IS. Human obesity: a heritable neurobehavioral disorder that is highly sensitive to environmental conditions. Diabetes 2008; 57: 2905-2910.
103. Clement K, Ferre P. Genetics and the pathophysiology of obesity. Pediatr Res 2003; 53:721-725.
104. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003-2006. JAMA 2008; 299:2401-2405.
105. Voorheuve PG, van den Akker EL, van Rossum EF, et al. Glucocorticoid receptor gene variant is associated with increased body fatness in young-sters. Clin Endocrinol 2009; 71:518-523.
106. Kumsta R, Entringer S, Koper JW, et al. Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus-pitui-tary- adrenal axis responses to psychosocial stress. Biol Psychiatry 2007; 62:863-869.
107. Wadhwa PD, Buss C, Entringer S, Swanson JM. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med 2009; 27:358-368.
108. Swanson JM, Entringer S, Buss C, Wadhwa PD. Developmental origins of health and disease: environmental exposures. Semin Reprod Med 2009; 27:391-402.
109. Flo K, Wilsgaard T, Acharya G. Relation between utero-placental and feto-placental circulations: a longitudinal study. Acta Obstet Gynecol Scand 2010; 89:1270-1275.
110. Ebbing C, Rasmussen S, Godfrey KM, et al. Fet al superior mesenteric artery: longitudinal reference ranges and evidence of regulatory linkto portal liver circulation. Early Hum Dev 2009; 85:207-213.
111. Chang CH, Yu CH, Chang FM, et al. Assessment of fet al adrenal gland volume using three-dimensional ultrasound. Ultrasound Med Biol 2002; 28:1383-1387.
112. Chang CH, Yu CH, Ko HC, et al. Predicting fet al growth restriction with liver volume by three-dimensional ultrasound: efficacyevaluation. Ultrasound Med Biol 2006; 32:13-17.
113. Lee W, Balasubramaniam M, Deter RL, et al. Fet al growth parameters and birth weight: their relationship to neonatal body composition. Ultrasound Obstet Gynecol 2009; 33:441-446.
114. Lee W, Deter RL, McNie B, et al. Individualized growth assessment of fet al soft tissue using fractional thigh volume. Ultrasound Obstet Gynecol 2004; 24:766-774.
115. Hu HH, Kim HW, Nayak KS, Goran MI. Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring) 2010; 18:841-847.
116. Hu HH,Smith DLJr, Nayak KS, et al. Identification ofbrown adiposetissue in mice with fat-water IDEAL-MRI. J Magn Reson Imaging 2010; 31:1195-1202.
117. Kirchner S, Kieu T, Chow C, et al. Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Mol Endocrinol 2010; 24:526-539.
118. Wood SN. Stable and efficient multiple smoothing parameter estimation for generalized additive models. J Am Stat Assoc 2004; 99:673-686.
119. Hedeker D, Gibbons R. In: Balding DJ,Cressie NAC, Fisher NI, et al., editors. Longitudinal data analysis. Hoboken, NJ: Wiley; 2006.
120. Raudenbush SW, Liu X. Effect of study duration, frequency of observation, and sample size on power in studies of group differences in polynomial change. Psychol Methods 2001; 6:387-401.
121. Singer JD, Willett JB. Applied longitudinal data analysis: modeling change and event occurence. New York: Oxford University Press; 2003.
122. Astrup A, Buemann B, Toubro S, et al. Lowresting metabolic rate in subjects predisposed to obesity: a role for thyroid status. Am J Clin Nutr 1996; 63:879-883.
123. Wing RR, Hill JO. Success ful weight loss maintenance. Annu Rev Nutr 2001; 21:323-341.
124. Kaplan RM. Should medicare reimburse providers for weight loss inter-ventions? Am Psychol 2007; 62:217-219.